Nasdaq - Delayed Quote USD

Virtus KAR Health Sciences P (AAAEX)

31.24
+0.14
+(0.45%)
At close: May 22 at 8:00:01 PM EDT

Top 10 Holdings (50.00% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 11.26%
AbbVie Inc. 5.04%
UnitedHealth Group Incorporated 4.64%
The Cooper Companies, Inc. 4.60%
Merck & Co., Inc. 4.49%
IDEXX Laboratories, Inc. 4.26%
Edwards Lifesciences Corporation 4.15%
West Pharmaceutical Services, Inc. 4.02%
Vertex Pharmaceuticals Incorporated 3.77%
Danaher Corporation 3.76%

Sector Weightings

SectorAAAEX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.73%
Stocks 99.27%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average AAAEX Category Average
Price/Earnings 0.02 24.55
Price/Book 0.18 5.28
Price/Sales 0.33 2.06
Price/Cashflow 0.04 17.54
Median Market Cap 73,200.74 34,862.81
3 Year Earnings Growth 3.57 32.48

Bond Holdings

Performance & Risk

YTD Return 6.18%
5y Average Return 0.00%
Rank in Category (ytd) 20
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.88
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Virtus
Net Assets 144.35M
YTD Return 3.41%
Yield 0.00%
Morningstar Rating
Inception Date Dec 22, 2014

Fund Summary

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Related Tickers